Insider Trading & Ownership - Levine Mark S.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Levine Mark S.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-05-22
Sale
2024-05-24
4:10 pm
Immunovant Inc.IMVTLevine Mark S.
Chief Legal Officer
3,242$29.65$96,125339,914
(Direct)
View
2024-04-24
Sale
2024-04-26
5:18 pm
Immunovant Inc.IMVTLevine Mark S.
Chief Legal Officer
3,963$28.9$114,531343,156
(Direct)
View
2024-04-17
Sale
2024-04-19
6:06 pm
Immunovant Inc.IMVTLevine Mark S.
Chief Legal Officer
9,827$29.06$285,554347,119
(Direct)
View
2024-02-22
Sale
2024-02-23
4:18 pm
Immunovant Inc.IMVTLevine Mark S.
Chief Legal Officer
2,134$36.15$77,144301,968
(Direct)
View
2024-01-26
Sale
2024-01-29
4:12 pm
Immunovant Inc.IMVTLevine Mark S.
Chief Legal Officer
3,027$37.92$114,778304,102
(Direct)
View
2023-11-22
Sale
2023-11-24
2:41 pm
Immunovant Inc.IMVTLevine Mark S.
Chief Legal Officer
3,252$32.78$106,598307,129
(Direct)
View
2023-10-25
Sale
2023-10-27
4:04 pm
Immunovant Inc.IMVTLevine Mark S.
Chief Legal Officer
4,107$34.66$142,349310,381
(Direct)
View
2023-08-24
Sale
2023-08-25
5:05 pm
Immunovant Inc.IMVTLevine Mark S.
Chief Legal Officer
12,286$20.3$249,406314,488
(Direct)
View
2023-07-26
Sale
2023-07-27
4:33 pm
Immunovant Inc.IMVTLevine Mark S.
Chief Legal Officer
3,917$21.63$84,725326,774
(Direct)
View
2023-04-25
Sale
2023-04-26
4:08 pm
Immunovant Inc.IMVTLevine Mark S.
Chief Legal Officer
2,633$16.29$42,892330,691
(Direct)
View
2023-01-26
Sale
2023-01-27
07:20 am
Immunovant Inc.IMVTLevine Mark S.
Chief Legal Officer
10,156$18.51$187,988245,660
(Direct)
View
2021-07-19
Sale
2021-07-20
8:45 pm
Flexion Therapeutics IncFLXNLevine Mark S.
General Counsel
3,945$6.45$25,445133,486
(Direct)
View
2021-01-05
Sale
2021-01-07
5:52 pm
Flexion Therapeutics IncFLXNLevine Mark S.
General Counsel
6,829$11.13$76,007107,431
(Direct)
View
2020-01-03
Sale
2020-01-07
4:35 pm
Flexion Therapeutics IncFLXNLevine Mark S.
General Counsel
3,724$0$043,487
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-04-02
Option Award
2024-04-04
4:37 pm
N/A
2034-04-02
Immunovant Inc.IMVTLevine Mark S.
Chief Legal Officer
123,701$0425,669
(Direct)
View
2023-04-12
Option Award
2023-04-14
4:24 pm
N/A
2033-04-12
Immunovant Inc.IMVTLevine Mark S.
Chief Legal Officer
201,485$0447,145
(Direct)
View
2022-08-17
Option Award
2022-08-19
4:57 pm
N/A
2032-08-17
Immunovant Inc.IMVTLevine Mark S.
Chief Legal Officer
282,464$0425,464
(Direct)
View
2022-01-28
Option Award
2022-01-31
5:01 pm
N/A
2032-01-28
Immunovant Inc.IMVTLevine Mark S.
Chief Legal Officer
526,000$0526,000
(Direct)
View
2021-11-19
Disposition
2021-11-19
10:08 am
N/A
2027-06-25
Flexion Therapeutics IncFLXNLevine Mark S.
General Counsel
211,833$00
(Direct)
View
2021-11-19
Disposition
2021-11-19
10:08 am
N/A
N/A
Flexion Therapeutics IncFLXNLevine Mark S.
General Counsel
133,486$8.50
(Direct)
View
2021-03-01
Option Award
2021-03-03
6:31 pm
N/A
2031-02-28
Flexion Therapeutics IncFLXNLevine Mark S.
General Counsel
50,000$0157,431
(Direct)
View
2020-07-16
Option Award
2020-07-20
9:24 pm
N/A
N/A
Flexion Therapeutics IncFLXNLevine Mark S.
General Counsel
38,750$0114,260
(Direct)
View
2020-06-22
Option Award
2020-06-24
4:12 pm
N/A
N/A
Flexion Therapeutics IncFLXNLevine Mark S.
General Counsel
1,023$10.8375,510
(Direct)
View
2020-03-02
Option Award
2020-03-03
4:16 pm
N/A
2030-03-01
Flexion Therapeutics IncFLXNLevine Mark S.
General Counsel
46,500$089,987
(Direct)
View